DUARTE, Calif., Feb. 25, 2025 /PRNewswire/ — Prolacta Bioscience, the world’s leading hospital provider of 100% human milk-based nutritional products, today announced the U.S. Food and Drug ...
DUARTE, Calif., Feb. 19, 2026 /PRNewswire/ -- Prolacta Bioscience® today announced that Japan's Ministry of Health, Labour and Welfare (MHLW) has approved PreemieFort® Enteral Solution, a 100% human ...
DUARTE, Calif., Oct. 14, 2025 /PRNewswire/ — Prolacta Bioscience®, the world’s leading hospital provider of 100% human milk-based nutritional products for critically ill and premature infants, ...
"Prematurity Awareness Month is an important time to raise awareness about the challenges and triumphs faced by premature and critically ill infants, as well as their families," said Melinda Elliott, ...
Surgifort(R) Human Milk Fortifier, Developed by Prolacta Bioscience, Is the First Human Milk-Based Nutritional Fortifier Indicated for Term Infants DUARTE, Calif., Feb. 25, 2025 /PRNewswire/ -- ...
Surgifort® Human Milk Fortifier, Developed by Prolacta Bioscience, Is the First Human Milk-Based Nutritional Fortifier Indicated for Term Infants Surgifort fortifier is the latest addition to Prolacta ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results